Search
for
Sort by
Research 31–60 of 51
- Advancing Design Strategy of PROTACs for Cancer Therapy
- Exploring extracellular vesicles as novel therapeutic agents for intervertebral disc degeneration: delivery, applications, and mechanisms
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Beta Human Papillomavirus and Merkel Cell Polyomavirus in Skin Neoplasms
- 4‐octyl itaconate alleviates cisplatin‐induced ferroptosis possibly via activating the NRF2/HO‐1 signalling pathway
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Proteomic Analysis of Two Stem Cell Secretomes Used in Combination in a Topical Skin Care Product That Has Demonstrated Efficacy in a Double-Blinded, Vehicle-Controlled Clinical Trial
- p63 in skin homeostasis and disease: molecular mechanisms and therapeutic potentials
- Exploring the mechanism of Platycladi Cacumen in intervening androgenetic alopecia based on network pharmacology, molecular docking, and molecular dynamics simulation
- Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars
- A State-of-the-Art Overview on (Epi)Genomics and Personalized Skin Rejuvenating Strategies
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Exosome‐derived long non‐coding RNA AC010789.1 modified by FTO and hnRNPA2B1 accelerates growth of hair follicle stem cells against androgen alopecia by activating S100A8/Wnt/β‐catenin signalling
- Molecular Morbidity Score–Can MicroRNAs Assess the Burden of Disease?
- Table_1_Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea.xlsx
- H3K9me3 controls epidermis morphogenesis by regulating RNA Pol II dynamics at developmental promoters and enhancers
- Biomedical applications of organoids in genetic diseases
- Ox40-Cre–mediated deletion of BRD4 reveals an unexpected phenotype of hair follicle stem cells in alopecia
- Identification of A p300–SP1–BRD4 Transcriptional Axis as a Key Driver of AR Hyperactivation in Polycystic Ovarian Syndrome
- Charting the Bromodomain BRD4: Towards the Identification of Novel Inhibitors with Molecular Similarity and Receptor Mapping
- Oncogenic senescence: a multi-functional perspective
- 575 INTASYL self-delivering RNAi: A flexible platform to treat dermatological malignancies
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- Honokiol protects skin cells against inflammation, collagenolysis, apoptosis, and senescence caused by cigarette smoke damage
- Molecular pathology of skin adnexal tumours